New Severe Asthma Treatment Exdensur Approved by TGA
The Therapeutic Goods Administration has approved Exdensur, a new maintenance treatment for Australians aged over 12 living with severe asthma and chronic rhinosinusitis with nasal polyps, according to announcements from the regulatory body and drug manufacturer GSK Australia. The therapy targets approximately 200,000 Australians affected by severe asthma symptoms, offering a newly registered clinical option … Read more